Skip to content

Clinical trials

Withdrawn Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Withdrawn Country / region: United States Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20032
20053
20064
20073
200810
20099
20106
20114
20129
20137
201416
20158
20166
20178
20186
201911
20207
202111
202213
202312
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn174

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center7
Mayo Clinic5
Duke University4
National Cancer Institute (NCI)4
Stanford University4
University of California, Irvine4
University of Southern California4
Memorial Sloan Kettering Cancer Center3
Milton S. Hershey Medical Center3
Northwestern University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms174
Triple Negative Breast Neoplasms10
Neoplasm Metastasis8
Carcinoma, Intraductal, Noninfiltrating7
Colorectal Neoplasms7
Lung Neoplasms7
Brain Neoplasms5
Breast Neoplasms, Male5
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.